Stanford Downgrades Ceradyne (CRDN) to Sell

February 10, 2009 2:17 PM EST

Earlier, Stanford Group downgradeed Ceradyne (Nasdaq: CRDN) from Hold to Sell, citing long-term concerns with the XSAPI body armor business.

Shares of Ceradyne have fallen more than 15% today. The stock most recently traded at $20.79.

Ceradyne, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of technical ceramic products, powders, and components for defense, industrial, automotive/diesel, and commercial applications in the United States.


Related Categories

Downgrades

Stocks Mentioned

CRDN 16.91

+0.00 +0.00%
Volume: 165,184
Track CRDN


Related Entities



Comments

Stanford Group
Jeff on Feb 18, 2009 02:52 PM

Thinking you guys have by now heard of Stanford Group given the latest new... They have no credibility given the recent allegations. It is too bad that Stanford wasn't exposed prior to "downgrading" CRDN

CRDN
Roger on Feb 10, 2009 05:26 PM

Never heard of this group. I noticed quite a few shares traded down this morning which got me to thinking does somebody know something I don't and are they shorting the stock? I bet the leak on this made some people a lot of money. CRDN has about $11 cash per share and will probably add at least 2.00 to that this year. Stock is cheap and I am a buyer of more.

DOWNGRADE
JOHN WOZNIAK on Feb 10, 2009 03:35 PM

WHO IN THE WORLD IS THE STANFORD GROUP ? BECAUSE THEY OPENED THEIR BIG MOUTH I AM DOWN 15 %, AND GOING LOWER. THANKS A LOT !


Add Your Comment